Literature DB >> 11462021

Efficient hepatitis delta virus RNA replication in avian cells requires a permissive factor(s) from mammalian cells.

Y T Liu1, R Brazas, D Ganem.   

Abstract

Hepatitis delta virus (HDV) is a highly pathogenic human RNA virus whose genome is structurally related to those of plant viroids. Although its spread from cell to cell requires helper functions supplied by hepatitis B virus (HBV), intracellular HDV RNA replication can proceed in the absence of HBV proteins. As HDV encodes no RNA-dependent RNA polymerase, the identity of the (presumably cellular) enzyme responsible for this reaction remains unknown. Here we show that, in contrast to mammalian cells, avian cells do not support efficient HDV RNA replication and that this defect cannot be rescued by provision of HDV gene products in trans. Contrary to earlier assertions, this defect is not due to enhanced apoptosis triggered in avian cells by HDV. Fusion of avian cells to mammalian cells rescues HDV replication in avian nuclei, indicating that the nonpermissive phenotype of avian cells is not due to the presence of dominantly acting inhibitors of replication. Rather, avian cells lack one or more essential permissive factors present in mammalian cells. These results set the stage for the identification of such factors and also explain the failure of earlier efforts to transmit HDV infection to avian hosts harboring indigenous hepadnaviruses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11462021      PMCID: PMC114984          DOI: 10.1128/JVI.75.16.7489-7493.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen.

Authors:  M Y Kuo; M Chao; J Taylor
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

2.  The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus.

Authors:  F L Chang; P J Chen; S J Tu; C J Wang; D S Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

3.  A specific base transition occurs on replicating hepatitis delta virus RNA.

Authors:  G X Luo; M Chao; S Y Hsieh; C Sureau; K Nishikura; J Taylor
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

4.  Isolation and characterization of an avian myogenic cell line.

Authors:  P B Antin; C P Ordahl
Journal:  Dev Biol       Date:  1991-01       Impact factor: 3.582

5.  Hepatitis delta virus infection in Pekin ducks chronically infected by the duck hepatitis B virus.

Authors:  A Ponzetto; M Rapicetta; B Forzani; A Smedile; C Hele; G Morace; A M di Rienzo; P Palladino; L Avanzini; J L Gerin
Journal:  Prog Clin Biol Res       Date:  1987

6.  Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication.

Authors:  M Chao; S Y Hsieh; J Taylor
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

7.  Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiologic and clinical survey.

Authors:  G Saracco; S Macagno; F Rosina; M Rizzetto
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

8.  Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity.

Authors:  M F Chang; S C Baker; L H Soe; T Kamahora; J G Keck; S Makino; S Govindarajan; M M Lai
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

9.  Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela.

Authors:  S C Hadler; M De Monzon; A Ponzetto; E Anzola; D Rivero; A Mondolfi; A Bracho; D P Francis; M A Gerber; S Thung
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

10.  Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck.

Authors:  A Ponzetto; P J Cote; H Popper; B H Hoyer; W T London; E C Ford; F Bonino; R H Purcell; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.